nirogacestat,lenalidomide,teclistamab,daratumumab,pomalidomide,bortezomib
takeda,springworks therapeutics,janssen,genmab,bms
['majestec-2', 'mmsm', 'majestec,(-majestec-1),(-majestec1),(-majestec 1),(-majestec-3),(-majestec3),(-majestec 3),(-majestec-i),(-majestec i),(-majesteci)']
with two fatal ae s and 4 febrile neutropenia in a small cohort of 32 patients, we should be cautious in our enthusiasm of bringing tec-dara-len for frontline treatment of elderly transplant ineligible patients. #mmsm #ash22 
Cancer doctor at @huntsmancancer with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. No COI. Views own.